Company | Price d* | Change d* | Volume, Avg. k, d* | Market Cap. d* | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding d* | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Manufacturers—General Average | - - | - - | - - | 139,755.28 | 8,801.76 | 500.71 | 20,251.74 | 835.05 | 0.01 | 2.6132 | 0.34 | 0.6385 | -0.0155 | 0.00 | 0.03 | 0.8630 | - - | ||
Maximum | - - | - - | - - | 754,449.00 | 21,382.00 | 4,762.00 | 153,378.00 | 3,847.00 | 0.04 | 76.3636 | 2.71 | 0.8250 | 0.3012 | 0.05 | 0.53 | 3.5022 | - - | ||
Minimum | - - | - - | - - | 0.00 | 91.00 | -11,911.00 | -27,870.00 | -2,626.00 | 0.00 | -335.6404 | -5.89 | 0.0683 | -1.0039 | -0.12 | -0.72 | 0.0000 | - - | ||
BP p.l.c. BPAQF | 4.85 | 0.07 1.46% | 10 vs. 62 | 77,263.00 | 48,662.00 | 2,263.00 | 1,285.00 | 0.00 | 0.1300 | 11.1223 | 0.0121 | 0.1953 | 0.0465 | 0.0325 | 0.0082 | 0.7658 | 15,930.00 | ||
AstraZeneca PLC AZNCF | 129.20 | 0.00 0.00% | 0 vs. 1 | 200,298.00 | 12,622.00 | 2,179.00 | - - | - - | 1.4000 | - - | - - | 0.7521 | - - | - - | - - | - - | 1,550.00 | ||
Vodafone Group Public Limited Company VODPF | 0.85 | 0.00 0.00% | 2 vs. 10 | 22,119.00 | 14,895.00 | 1,497.00 | 8,126.00 | -114,660.00 | 0.0554 | 3.7500 | 0.0545 | 0.3788 | 0.1005 | 0.0250 | 0.0104 | 0.7807 | 26,023.00 | ||
GSK plc GLAXF | 17.61 | 0.00 0.00% | 1 vs. 3 | 71,831.00 | 7,363.00 | 1,046.00 | 376.00 | 7,935.00 | 0.2600 | 15.5725 | 0.0087 | 0.7369 | 0.1421 | 0.0756 | 0.0179 | 0.5737 | 4,078.00 | ||
National Grid plc NGGTF | 12.02 | 0.00 0.00% | 0 vs. 17 | 58,730.00 | 11,361.00 | 1,162.00 | -610.00 | 32,066.00 | 0.2900 | 9.6228 | 0.0044 | 0.3134 | 0.1023 | 0.0389 | 0.0118 | 0.6747 | 4,886.00 |